GENEVIEVE FLORENCE BASANAGA

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NORTH PLAINFIELD, NJ NPI 1114600152

General Payments — all program years on this page

$859.84

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 45
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $656.37 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $656.3739

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $155.2010
Bayer HealthCare Pharmaceuticals Inc. $138.379
Acerta Pharma LLC $134.916
Amgen Inc. $108.107
Novo Nordisk AS $103.116
Phadia US Inc. $16.681

By program year

Program yearAmountRecords
2023 $203.476
2024 $656.3739

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1067579026 Phadia US Inc. $16.68 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086100969 Bayer Healthcare Pharmaceuticals Inc. $11.85 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086103069 Bayer Healthcare Pharmaceuticals Inc. $12.26 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086105466 Bayer Healthcare Pharmaceuticals Inc. $12.51 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086298440 Bayer Healthcare Pharmaceuticals Inc. $15.62 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086317055 Bayer Healthcare Pharmaceuticals Inc. $17.60 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086333639 Bayer Healthcare Pharmaceuticals Inc. $20.71 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086351138 Bayer Healthcare Pharmaceuticals Inc. $14.41 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086360206 Bayer Healthcare Pharmaceuticals Inc. $16.59 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086365331 Bayer Healthcare Pharmaceuticals Inc. $16.82 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100236106 Novo Nordisk Inc $17.31 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100447939 Novo Nordisk Inc $15.51 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100541220 Novo Nordisk Inc $16.99 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100546750 Novo Nordisk Inc $17.51 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100561695 Novo Nordisk Inc $19.68 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100627634 Novo Nordisk Inc $16.11 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104560126 AstraZeneca Pharmaceuticals LP $13.67 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105459848 AstraZeneca Pharmaceuticals LP $14.33 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105619725 AstraZeneca Pharmaceuticals LP $59.73 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105726937 AstraZeneca Pharmaceuticals LP $16.71 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105735039 AstraZeneca Pharmaceuticals LP $13.73 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105839739 AstraZeneca Pharmaceuticals LP $16.74 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115441561 Amgen Inc. $15.16 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115441566 Amgen Inc. $14.74 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117502512 Amgen Inc. $16.51 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117502514 Amgen Inc. $15.64 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117502516 Amgen Inc. $15.46 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117502518 Amgen Inc. $15.00 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117502520 Amgen Inc. $15.59 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135639262 Lilly USA, LLC $15.93 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135651141 Lilly USA, LLC $12.00 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135671816 Lilly USA, LLC $15.51 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135671818 Lilly USA, LLC $13.79 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135671820 Lilly USA, LLC $15.81 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135671822 Lilly USA, LLC $17.34 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135674236 Lilly USA, LLC $16.40 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135674238 Lilly USA, LLC $16.19 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135689256 Lilly USA, LLC $14.05 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135689258 Lilly USA, LLC $18.18 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.